<i>In vivo</i> evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using 18F-fluoromisonidazole PET-CT
Koji Maruyama(Hyogo Brain and Heart Center), Takamichi Murakami(Kobe University Hospital), Munenobu Nogami(Foundation for Biomedical Research and Innovation), Takuya Okada(Kobe University), Koji Sasaki(Gunma Prefectural College of Health Sciences), Jun Hatazawa(Osaka University of Pharmaceutical Sciences), Eisuke Ueshima(Kobe University), Takeshi Ueha(Kobe University), Tomoyuki Gentsu(Kobe University), Masato Yamaguchi(Jikei University School of Medicine), Kayako Isohashi(The University of Osaka), Hayato Ikeda(The University of Osaka), Keitaro Sofue(Kobe University), Yoshitada Sakai(Kobe University), Koji Sugimoto(Kobe University), Yasukazu Kanai(The University of Osaka)
Cited by 2
Related Papers
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
|Hepatology Research|2023|281
Idiopathic Pulmonary Fibrosis. Epidemiologic Approaches to Occupational Exposure
|American Journal of Respiratory and Critical Care Medicine|1994|269